Logo image of CCEP

COCA-COLA EUROPACIFIC PARTNE (CCEP) Stock Fundamental Analysis

NASDAQ:CCEP - Nasdaq - GB00BDCPN049 - Common Stock - Currency: USD

95.52  +0.07 (+0.07%)

After market: 95.52 0 (0%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CCEP. CCEP was compared to 32 industry peers in the Beverages industry. While CCEP is still in line with the averages on profitability rating, there are concerns on its financial health. CCEP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CCEP had positive earnings in the past year.
CCEP had a positive operating cash flow in the past year.
In the past 5 years CCEP has always been profitable.
CCEP had a positive operating cash flow in each of the past 5 years.
CCEP Yearly Net Income VS EBIT VS OCF VS FCFCCEP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

CCEP has a Return On Assets (4.56%) which is in line with its industry peers.
CCEP's Return On Equity of 16.70% is fine compared to the rest of the industry. CCEP outperforms 62.50% of its industry peers.
CCEP has a Return On Invested Capital (7.00%) which is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CCEP is below the industry average of 11.57%.
Industry RankSector Rank
ROA 4.56%
ROE 16.7%
ROIC 7%
ROA(3y)5.14%
ROA(5y)4.27%
ROE(3y)19.29%
ROE(5y)16.02%
ROIC(3y)7.84%
ROIC(5y)6.6%
CCEP Yearly ROA, ROE, ROICCCEP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

1.3 Margins

CCEP's Profit Margin of 6.94% is in line compared to the rest of the industry. CCEP outperforms 56.25% of its industry peers.
CCEP's Profit Margin has declined in the last couple of years.
CCEP has a Operating Margin (10.46%) which is in line with its industry peers.
In the last couple of years the Operating Margin of CCEP has declined.
Looking at the Gross Margin, with a value of 35.31%, CCEP is doing worse than 81.25% of the companies in the same industry.
CCEP's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 10.46%
PM (TTM) 6.94%
GM 35.31%
OM growth 3Y1.73%
OM growth 5Y-1.57%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.58%
GM growth 5Y-1.5%
CCEP Yearly Profit, Operating, Gross MarginsCCEP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CCEP is still creating some value.
CCEP has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CCEP has more shares outstanding
CCEP has a better debt/assets ratio than last year.
CCEP Yearly Shares OutstandingCCEP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
CCEP Yearly Total Debt VS Total AssetsCCEP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

CCEP has an Altman-Z score of 2.19. This is not the best score and indicates that CCEP is in the grey zone with still only limited risk for bankruptcy at the moment.
CCEP has a Altman-Z score of 2.19. This is comparable to the rest of the industry: CCEP outperforms 43.75% of its industry peers.
CCEP has a debt to FCF ratio of 5.34. This is a neutral value as CCEP would need 5.34 years to pay back of all of its debts.
The Debt to FCF ratio of CCEP (5.34) is better than 75.00% of its industry peers.
CCEP has a Debt/Equity ratio of 1.17. This is a high value indicating a heavy dependency on external financing.
CCEP has a Debt to Equity ratio of 1.17. This is in the lower half of the industry: CCEP underperforms 71.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 5.34
Altman-Z 2.19
ROIC/WACC0.91
WACC7.68%
CCEP Yearly LT Debt VS Equity VS FCFCCEP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

CCEP has a Current Ratio of 0.81. This is a bad value and indicates that CCEP is not financially healthy enough and could expect problems in meeting its short term obligations.
CCEP has a Current ratio of 0.81. This is in the lower half of the industry: CCEP underperforms 78.13% of its industry peers.
CCEP has a Quick Ratio of 0.81. This is a bad value and indicates that CCEP is not financially healthy enough and could expect problems in meeting its short term obligations.
CCEP's Quick ratio of 0.62 is on the low side compared to the rest of the industry. CCEP is outperformed by 68.75% of its industry peers.
Industry RankSector Rank
Current Ratio 0.81
Quick Ratio 0.62
CCEP Yearly Current Assets VS Current LiabilitesCCEP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. Growth

3.1 Past

CCEP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.31%.
Measured over the past 5 years, CCEP shows a small growth in Earnings Per Share. The EPS has been growing by 5.80% on average per year.
The Revenue has grown by 11.67% in the past year. This is quite good.
CCEP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 11.21% yearly.
EPS 1Y (TTM)-15.31%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%-24.06%
Revenue 1Y (TTM)11.67%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%13.78%

3.2 Future

CCEP is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.28% yearly.
Based on estimates for the next years, CCEP will show a small growth in Revenue. The Revenue will grow by 3.08% on average per year.
EPS Next Y5.49%
EPS Next 2Y7.39%
EPS Next 3Y7.9%
EPS Next 5Y9.28%
Revenue Next Year3.24%
Revenue Next 2Y3.41%
Revenue Next 3Y3.58%
Revenue Next 5Y3.08%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CCEP Yearly Revenue VS EstimatesCCEP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
CCEP Yearly EPS VS EstimatesCCEP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 26.53 indicates a quite expensive valuation of CCEP.
CCEP's Price/Earnings ratio is in line with the industry average.
CCEP's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.30.
CCEP is valuated rather expensively with a Price/Forward Earnings ratio of 19.30.
CCEP's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, CCEP is valued at the same level.
Industry RankSector Rank
PE 26.53
Fwd PE 19.3
CCEP Price Earnings VS Forward Price EarningsCCEP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

CCEP's Enterprise Value to EBITDA is on the same level as the industry average.
78.13% of the companies in the same industry are more expensive than CCEP, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.7
EV/EBITDA 15.3
CCEP Per share dataCCEP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CCEP does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)4.83
PEG (5Y)4.57
EPS Next 2Y7.39%
EPS Next 3Y7.9%

5

5. Dividend

5.1 Amount

CCEP has a Yearly Dividend Yield of 2.32%.
CCEP's Dividend Yield is a higher than the industry average which is at 3.03.
CCEP's Dividend Yield is comparable with the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 2.32%

5.2 History

On average, the dividend of CCEP grows each year by 9.91%, which is quite nice.
CCEP has paid a dividend for at least 10 years, which is a reliable track record.
CCEP has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)9.91%
Div Incr Years4
Div Non Decr Years4
CCEP Yearly Dividends per shareCCEP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2

5.3 Sustainability

64.17% of the earnings are spent on dividend by CCEP. This is not a sustainable payout ratio.
The dividend of CCEP is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP64.17%
EPS Next 2Y7.39%
EPS Next 3Y7.9%
CCEP Yearly Income VS Free CF VS DividendCCEP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B
CCEP Dividend Payout.CCEP Dividend Payout, showing the Payout Ratio.CCEP Dividend Payout.PayoutRetained Earnings

COCA-COLA EUROPACIFIC PARTNE

NASDAQ:CCEP (7/11/2025, 8:00:02 PM)

After market: 95.52 0 (0%)

95.52

+0.07 (+0.07%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)04-29 2025-04-29
Earnings (Next)N/A N/A
Inst Owners37.53%
Inst Owner Change0%
Ins Owners0.22%
Ins Owner ChangeN/A
Market Cap43.97B
Analysts77.27
Price Target96.23 (0.74%)
Short Float %1.97%
Short Ratio2.36
Dividend
Industry RankSector Rank
Dividend Yield 2.32%
Yearly Dividend2.33
Dividend Growth(5Y)9.91%
DP64.17%
Div Incr Years4
Div Non Decr Years4
Ex-Date05-16 2025-05-16 (0.9)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.18%
PT rev (3m)3.77%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-1.26%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.97%
Valuation
Industry RankSector Rank
PE 26.53
Fwd PE 19.3
P/S 1.84
P/FCF 17.7
P/OCF 12.27
P/B 4.42
P/tB N/A
EV/EBITDA 15.3
EPS(TTM)3.6
EY3.77%
EPS(NY)4.95
Fwd EY5.18%
FCF(TTM)5.4
FCFY5.65%
OCF(TTM)7.79
OCFY8.15%
SpS51.99
BVpS21.59
TBVpS-22.76
PEG (NY)4.83
PEG (5Y)4.57
Profitability
Industry RankSector Rank
ROA 4.56%
ROE 16.7%
ROCE 9.32%
ROIC 7%
ROICexc 7.57%
ROICexgc 42.27%
OM 10.46%
PM (TTM) 6.94%
GM 35.31%
FCFM 10.38%
ROA(3y)5.14%
ROA(5y)4.27%
ROE(3y)19.29%
ROE(5y)16.02%
ROIC(3y)7.84%
ROIC(5y)6.6%
ROICexc(3y)8.71%
ROICexc(5y)7.37%
ROICexgc(3y)64.53%
ROICexgc(5y)51.3%
ROCE(3y)10.42%
ROCE(5y)8.8%
ROICexcg growth 3Y8.99%
ROICexcg growth 5Y7.35%
ROICexc growth 3Y14.53%
ROICexc growth 5Y1.38%
OM growth 3Y1.73%
OM growth 5Y-1.57%
PM growth 3Y-0.93%
PM growth 5Y-5.22%
GM growth 3Y-1.58%
GM growth 5Y-1.5%
F-Score5
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 1.17
Debt/FCF 5.34
Debt/EBITDA 3.24
Cap/Depr 100.64%
Cap/Sales 4.59%
Interest Coverage 8.59
Cash Conversion 99.67%
Profit Quality 149.65%
Current Ratio 0.81
Quick Ratio 0.62
Altman-Z 2.19
F-Score5
WACC7.68%
ROIC/WACC0.91
Cap/Depr(3y)92.36%
Cap/Depr(5y)78.04%
Cap/Sales(3y)4.17%
Cap/Sales(5y)3.92%
Profit Quality(3y)141.19%
Profit Quality(5y)162.2%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.31%
EPS 3Y12.68%
EPS 5Y5.8%
EPS Q2Q%-24.06%
EPS Next Y5.49%
EPS Next 2Y7.39%
EPS Next 3Y7.9%
EPS Next 5Y9.28%
Revenue 1Y (TTM)11.67%
Revenue growth 3Y14.09%
Revenue growth 5Y11.21%
Sales Q2Q%13.78%
Revenue Next Year3.24%
Revenue Next 2Y3.41%
Revenue Next 3Y3.58%
Revenue Next 5Y3.08%
EBIT growth 1Y-4.98%
EBIT growth 3Y16.06%
EBIT growth 5Y9.46%
EBIT Next Year43.62%
EBIT Next 3Y17.56%
EBIT Next 5Y12.75%
FCF growth 1Y6.42%
FCF growth 3Y8.29%
FCF growth 5Y10.26%
OCF growth 1Y9.09%
OCF growth 3Y13.08%
OCF growth 5Y9.96%